Rheumatoid Arthritis: The link between thyroid dysfunction, cardiovascular disease and B cell targeting Hennie G. Raterman The printing of this thesis was supported financially by: AbbVie, Amgen, Dutch Arthritis foundation, Pfizer, Reade center for rehabilitation and rheumatology, Roche, Schildklier Organisaties Nederland, Teva Nederland bv and UCB Pharma bv. Copyright © Hennie G. Raterman, Monnickendam, the Netherlands, 2013 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system of any nature, or transmitted in any form or by any means, without prior permission of the author Cover design: Chantal Snackey Layout: Hennie Raterman English auditing: Tessa Dorhout Printed by: Ipskamp drukkers ISBN: 978-94-6191-814-7 VRIJE UNIVERSITEIT Rheumatoid Arthritis: The link between thyroid dysfunction, cardiovascular disease and B cell targeting ACADEMISCH PROEFSCHRIFT ter verkrijging van de graad Doctor aan de Vrije Universiteit Amsterdam, op gezag van de rector magnificus prof.dr. F.A. van der Duyn Schouten, in het openbaar te verdedigen ten overstaan van de promotiecommissie van de Faculteit der Geneeskunde op maandag 16 september 2013 om 13.45 uur in de aula van de universiteit, De Boelelaan 1105 door Hendricus Gerardus Raterman geboren te Amsterdam promotor: prof.dr. B.A.C. Dijkmans copromotoren: prof.dr. W.F. Lems dr. M.T. Nurmohamed dr. A.E. Voskuyl Contents INTRODUCTION Rheumatoid arthritis: The link between thyroid 9 dysfunction, cardiovascular disease and B cell targeting SECTION 1 Thyroid dysfunction and rheumatoid arthritis: more 23 than comorbidity Chapter 1.1 Hypothyroidism and cardiovascular diseases in rheumatoid 25 arthritis A Rheumatoid arthritis is associated with a high prevalence 25 of hypothyroidism that amplifies its cardiovascular risk Annals of the Rheumatic Diseases 2008 Feb; 67(2):229-32 B Coexistence of hypothyroidism with inflammatory arthritis 37 is associated with cardiovascular disease in women Annals of the Rheumatic Diseases 2012 Jul;71(7):1216-8 Chapter 1.2 The metabolic syndrome is amplified in hypothyroid 47 rheumatoid arthritis patients: a cross-sectional study Annals of the Rheumatic Diseases 2010 Jan;69(1):39-42 Chapter 1.3 Thyroid peroxidase antibodies in rheumatoid arthrtitis 59 A Increased prevalence of antithyroid antibodies in 59 rheumatoid arthritis (RA) patients with a low prevalence of hormonal alterations Autoimmunity 2008 Aug;41(5):337 B Increased progression of carotid intima media thickness in 63 thyroid peroxidase antibodies positive rheumatoid arthritis patients Submitted Chapter 1.4 Thyroid function upon biological treatment in rheumatoid 77 arthritis A Improvement of thyroid function in hypothyroid patients 77 with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study. Journal of rheumatology 2011 Feb;38(2):247-51 B Rituximab and thyroid function 91 Archives of internal Medicine 2009 Jun 8;169(11):1073-4 SECTION 2 Rituximab in rheumatoid arthritis: more than B cell 97 depletion Chapter 2.1 HDL protein composition alters from proatherogenic into less 99 atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab Annals of the Rheumatic Diseases 2013 Apr;72(4):560-5 Chapter 2.2 Pharmacogenomics in rituximab treated rheumatoid arthritis 119 patients A Pharmacological induction of interferon type I activity 119 following treatment with rituximab determines clinical response in rheumatoid arthritis Annals of the Rheumatic Diseases 2011 Jun;70(6):1153-9 B Interferon type I signature may predict non response 139 upon rituximab in rheumatoid arthritis patients Arthritis Research and Therapy 2012 Apr 27;14(2):R95 SUMMARY & DISCUSSION 159 DUTCHSUMMARY 175 (NEDERLANDSE SAMENVATTING) ACKNOWLEDGEMENTS 189 (DANKWOORD) ABOUT THE AUTHOR 195 INTRODUCTION
Description: